Available Technology

A Novel 12-Gene Prognostic Signature for Breast Cancer 2016-181

Benefits: 
Determines most effective treatment options for patient quality of life - Standardizes breast cancer prognoses
applications: 
Patent Status: 
Patent pending. Available for licensing or collaborative research.
Share to Facebook Share to Twitter Share to Google Plus Share to Linkedin